NARSAD Grantee and Colleagues Create New Model for Treatment of OCD

Stephanie Dulawa, Ph.D.
Stephanie Dulawa, Ph.D.

Currently, there is only one type of medication that has been shown to be effective in treating Obsessive-Compulsive Disorder (OCD). Serotonin Reuptake Inhibitors (SRIs), including clomipramine, have been shown to reduce symptoms in 40% - 60% of patients with OCD. Cognitive Behavioral Therapy (CBT) has also been shown to be effective.

“Now that we have this model, we actually could pursue these ideas for better treatments in a disease where there is only one successful pharmocological monotherapy,” said NARSAD Young Investigator Grantee Stephanie Dulawa, Ph.D.

Click here to read more

Add new comment

comments

Plain text

  • No HTML tags allowed.
  • Web page addresses and e-mail addresses turn into links automatically.
  • Lines and paragraphs break automatically.

Please note that researchers cannot give specific recommendations or advice about treatment; diagnosis and treatment are complex and highly individualized processes that require comprehensive face-to- face assessment. Please visit our "Ask an Expert" section to see a list of Q & A with NARSAD Grantees.
By submitting this form, you accept the Mollom privacy policy.